Targeting SEL1L3: A Potential Drug (G23231)

Target Name: SEL1L3

NCBI ID: G23231

SEL1L3

Targeting SEL1L3: A Potential Drug

SEL1L3 (FLJ41299) is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high levels in response to environmental stressors, such as heat, cold, and exercise.

SEL1L3 is unique because it has a unique structure that allows it to interact with other proteins in the HSP family. It has a calculated molecular weight of 13.9 kDa and a calculated pI of 6.5. This means that it is relatively small and has a relatively narrow range of affinity for the HSP protein.

SEL1L3 is involved in a number of cellular processes that are important for cell survival and function. For example, it is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. It is also involved in the regulation of cell growth, which is the process by which cells increase in size and complexity.

In addition to its role in cell biology, SEL1L3 is also a potential drug target. Its unique structure and its involvement in important cellular processes make it an attractive target for drug developers.

One way that SEL1L3 could be targeted with drugs is by inhibiting its ability to interact with other proteins in the HSP family. This could be done by targeting the protein's predicted active site, which is the region of the protein that is likely to be involved in its interactions with other proteins.

Another potential approach to targeting SEL1L3 is to block its ability to regulate cell adhesion. This could be done by inhibiting the activity of SEL1L3 itself or by blocking the activity of proteins that are regulated by SEL1L3.

Another potential approach to targeting SEL1L3 is to inhibit its ability to regulate cell growth. This could be done by inhibiting the activity of SEL1L3 itself or by blocking the activity of proteins that are regulated by SEL1L3.

Overall, SEL1L3 is a unique protein that is involved in a number of important cellular processes. Its structure and its involvement in these processes make it an attractive target for drug developers. Further research is needed to fully understand the potential of SEL1L3 as a drug target.

Protein Name: SEL1L Family Member 3

The "SEL1L3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEL1L3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets